LinkedIn

AsiaTIDES is a unique opportunity to update your knowledge of the latest research and manufacturing technologies for oligonucleotide- and peptide-based therapeutics and access this rapidly growing market area. Hear the latest reports from around the world – a program agenda not available at any other event in Japan – at a convenient forum in Tokyo. Get a comprehensive scientific update on: • Delivery technologies including intracellular targeting, chemical modifications, oral, liposomal and nanoparticle delivery • Understanding of microRNA from Santaris, miRagen and University of Tokyo • Manufacturing and analytical development for peptides and oligos • Regulatory considerations and guidance updates from Oligo Safety Working Group, ICHS6 and Regado • Valuable data on preclinical data and therapeutic candidates from around the world • Challenges and solutions for the delivery of siRNA and Peptide Therapeutics Plus, In-depth Tutorials on: •Bioanalytical Techniques for Oligonucleotides and Peptides •Lessons Learned on the Way to an IND from Real Life Experience with Oligonucleotides and Peptides